Information  X 
Enter a valid email address
  Print          More announcements

Tuesday 23 June, 2020

FTSE Russell

Hikma Pharmaceuticals

RNS Number : 8326Q
FTSE Russell
23 June 2020





Hikma Pharmaceuticals (UK): Shares in Issue and Investability Weight Change
Changes in FTSE UK Index Series

23 June 2020

Following the receipt of updated shareholder information for Hikma Pharmaceuticals, (UK, constituent) as a result of a secondary placing and concurrent share repurchase, please see details of affected indexes and effective dates below:




Effective From
Start of Trading

FTSE 100 Index

26 June 2020

FTSE 350 Index

26 June 2020

FTSE All-Share Index

26 June 2020

FTSE 350 Lower Yield Index

26 June 2020


 * The change to Index shares reflects the secondary placing only.







For further information please contact FTSE Russell Client Services at [email protected] or call:


+1800 653 680

Hong Kong

+852 2164 3333


+81 3 4563 6346


+44 (0) 20 7866 1810

New York

+1866 551 0617



Alternatively please visit our website at

Terms of Use | Copyright © 2020 FTSE Russell


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit

a d v e r t i s e m e n t